Moderna Inc., US60770K1079

Moderna stock pre-market at EUR 181.09: plus 1.46 percent

Published on 09/30/2026 at 08:36 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Moderna stock is at EUR 181.09 pre-market, up 1.46 percent versus the Lang & Schwarz prior close. The company is preparing to present Phase 3 melanoma data in October.

Aquarellmalerei der Cambridge-Skyline mit modernen Forschungsgebäuden am Charles River
Moderna Inc. (US60770K1034) präsentiert eine stimmungsvolle Aquarell-Ansicht der Cambridge-Skyline mit modernen Biotech-Forschungsgebäuden am Flussufer, Illustration mit AI erstellt.

Moderna stock is at EUR 181.09 pre-market on September 30, 2026, at 8:35 a.m. CEST, according to Lang & Schwarz. The price is up 1.46 percent versus the Lang & Schwarz prior close of EUR 178.48.

Pre-market price

Lang & Schwarz lists a bid of EUR 180.48 and an ask of EUR 181.70. The quote is from the pre-market period before the Xetra open.

Upcoming melanoma data

Moderna said detailed Phase 3 results for intismeran autogene, its personalized cancer therapy developed with Merck, are scheduled for presentation at the European Society for Medical Oncology Congress on October 24, according to a Yahoo Finance report published September 22.

A September 21 MT Newswires report carried by Yahoo Finance also said Moderna provided details on upcoming conference presentations, including Phase 3 data for intismeran autogene in resected stage IIB-IV melanoma.

Disclaimer...

en | US60770K1079 | MODERNA INC. | boerse | 70202263 | bgmi